Novo Nordisk’s diabetes pill slashes risk of cardiovascular complications by 14% after four years
Flags with the logos of Danish drugmaker Novo Nordisk, maker of the blockbuster diabetes and weight-loss treatments Ozempic and Wegovy are pictures while the companyContinue Reading